Literature DB >> 13129631

The impact of radiotherapy for carcinoma of the cervix on sexual function assessed using the LENT SOMA scales.

Susan E Davidson1, Meriel P Burns, Jacqueline A Routledge, Ric Swindell.   

Abstract

BACKGROUND AND
PURPOSE: As there are few studies examining the impact of radiotherapy on sexuality, we assessed the effect of radiotherapy for carcinoma of the cervix on sexual health and the ability of the LENT system to assess sexual function.
MATERIALS AND METHODS: Using the vagina and sexual dysfunction scales of the LENT SOMA scales, subjective scores were measured prospectively before initiation of radiotherapy for 89 women, and at the following times after the start of treatment: 21, 70, 200, 400, 600 and 800 days.
RESULTS: There was considerable variation in pre-radiotherapy scores that was not related to disease stage (P=0.054), but was related to patient age (P=0.037, for the average vagina scores and P=0.039 for the maximum vagina scores) The scores were influenced by prior surgery (P<0.0005 for maximum and average vagina scores, P=0.042 average and 0.017 maximum sexual dysfunction scores). For 48 patients for whom data were available at the first three time points, the vagina scores decreased significantly by 70 days compared to pre-radiotherapy scores, but not for sexual dysfunction. There was heterogeneity in the pattern of changes of scores over time: for some women there was no change in vagina subsection score, some increased, and some decreased.
CONCLUSIONS: The work has shown variation both in pre-treatment sexual function and in the pattern of changes seen following radiotherapy. Our questionnaire proved useful to score subjective sexual and vaginal problems as given in the LENT subjective scales. Further study is needed to assess the effectiveness of the scales in assessing late effects.

Entities:  

Mesh:

Year:  2003        PMID: 13129631     DOI: 10.1016/s0167-8140(03)00190-7

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

Review 1.  Vaginal dilator therapy for women receiving pelvic radiotherapy.

Authors:  Tracie Miles; Nick Johnson
Journal:  Cochrane Database Syst Rev       Date:  2014-09-08

2.  Radiation-induced morphological changes in the vagina.

Authors:  K Kirchheiner; E Fidarova; R A Nout; M P Schmid; A Sturdza; E Wiebe; A Kranz; S Polterauer; R Pötter; W Dörr
Journal:  Strahlenther Onkol       Date:  2012-09-29       Impact factor: 3.621

Review 3.  Vaginal dilator therapy for women receiving pelvic radiotherapy.

Authors:  Tracie Miles; Nick Johnson
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

4.  Assessment of treatment-induced female sexual morbidity in oncology: is this a part of routine medical follow-up after radical pelvic radiotherapy?

Authors:  I D White; H Allan; S Faithfull
Journal:  Br J Cancer       Date:  2011-09-06       Impact factor: 7.640

5.  A multi-institutional survey of the quality of life after treatment for uterine cervical cancer: a comparison between radical radiotherapy and surgery in Japan.

Authors:  Yuko Kaneyasu; Hisaya Fujiwara; Tetsuo Nishimura; Hideyuki Sakurai; Tomoko Kazumoto; Hitoshi Ikushima; Takashi Uno; Sunao Tokumaru; Yoko Harima; Hiromichi Gomi; Takafumi Toita; Midori Kita; Shin-Ei Noda; Takeo Takahashi; Shingo Kato; Ayako Ohkawa; Akiko Tozawa-Ono; Hiroki Ushijima; Yoko Hasumi; Yasuyuki Hirashima; Yuzuru Niibe; Tomio Nakagawa; Tomoyuki Akita; Junko Tanaka; Tatsuya Ohno
Journal:  J Radiat Res       Date:  2021-03-10       Impact factor: 2.724

Review 6.  Body Image, Sexuality, and Sexual Functioning in Women With Gynecologic Cancer: An Integrative Review of the Literature and Implications for Research.

Authors:  Christina M Wilson; Deborah B McGuire; Beth L Rodgers; R K Elswick; Sarah M Temkin
Journal:  Cancer Nurs       Date:  2021 Sep-Oct 01       Impact factor: 2.592

7.  Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) - a prospective, randomized, 2-armed phase-II-trial.

Authors:  Nathalie Arians; Matthias Häfner; Johannes Krisam; Kristin Lang; Antje Wark; Stefan A Koerber; Adriane Hommertgen; Jürgen Debus
Journal:  BMC Cancer       Date:  2020-01-21       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.